It “provokes a strong immune response” against the original strain of the virus and the Omicron variant, according to the British regulator.
Britain’s drug regulator announced Monday that it has approved a new generation of Moderna’s Covid-19 vaccine targeting the Omicron variant, a world first according to the lab. This version of the vaccine consists of a booster dose called “bivalent”, targeting half the original strain of the virus and half the Omicron variant and “causes a strong immune responseagainst both, including Omicron BA.4 and BA.5 subvariants, the MHRA said in a statement.
She “has been approved for booster doses for adults by the MHRA who concluded that it meets the UK regulator’s safety, quality and efficacy standards“, added the drug agency. The side effects noted aretypically low» and similar to those observed for the original serums, it is specified.
Read alsoModerna to build RNA vaccine research and production facility in UK
“What this bivalent vaccine gives us is a sharper tool in our toolbox to help protect us against this disease as the virus continues to evolve.“, underlined the director of the MHRA, June Raine, in a press release.
The general manager of Moderna Stéphane Bancel underlined for his part “the important role“what can this play”new generationof a vaccine in protection against Covid-19. He noted that the United Kingdom thus became the first country to approve a bivalent vaccine partly targeting Omicron, the variant that has become the most widespread in Europe.
The pandemic is “far from over” according to the WHO
Last week, the European Medicines Agency (EMA) said it was aiming for approval as early as the fall of a Pfizer/BioNTech Covid vaccine targeting two subvariants of the rapidly spreading Omicron strain, BA.4 and BA.5.
Read alsoCovid-19: a vaccine targeting Omicron subvariants soon to be approved in Europe
While vaccinations have helped reduce hospitalizations and deaths from Covid-19, which first emerged in China in late 2019, current injections mainly target earlier strains of the disease.
The World Health Organization (WHO) warned in July that the pandemic was “far from overdue to the spread of Omicron subvariants, the lifting of health restrictions and the drop in testing. Covid cases spiked globally in late spring and early summer, driven by newer variants, but have since started to level off in Europe.
European countries are now starting to look to autumn and winter, when cases are expected to rise again. The United Kingdom is one of the countries most affected in Europe by the pandemic with nearly 180,000 deaths. While mortality has fallen sharply thanks to vaccination, the country regularly experiences large waves of contamination but was one of the first in Europe to lift all restrictions last winter.
SEE ALSO – Moderna CEO announces phase 2 development of ‘custom’ skin cancer vaccine